|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Interest and other income (expenses), net | |||||
| Loss on loan extinguishment | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted-average common shares used to compute net loss per share attributable to | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other comprehensive gain (loss): | |||||
| Foreign currency translation adjustment | |||||
| Unrealized gain on cash equivalents | |||||
| Comprehensive loss |
Loading...